Retrospective Study
Copyright ©The Author(s) 2016.
World J Gastrointest Surg. Mar 27, 2016; 8(3): 238-245
Published online Mar 27, 2016. doi: 10.4240/wjgs.v8.i3.238
Table 3 Results after primary revision at last follow-up (n = 152)
Re-VBG n = 21 Mean ± SDcSG n = 16 Mean ± SDcRYGB n = 115 Mean ± SDCorrected P value
Re-VBGvscSGcRYGB vs Re-VBGcRYGBvscSG
Follow-up (mo)39.1 ± 48.749.3 ± 17.650.0 ± 33.3
Average %EWL after VBG (%)61.7 ± 27.038.7 ± 22.943.5 ± 25.0
Additional %EWL-14.6 ± 19.917.9 ± 32.7
Total %EWL (%)45.4 ± 25.556.6 ± 24.471.7 ± 23.80.6140.0060.025
Total body weight loss (%)18.4 ± 11.124.1 ± 11.630.4 ± 10.10.049< 0.0010.016
Change body mass index (kg/m2)8.1 ± 5.810.8 ± 5.813.5 ± 5.10.119< 0.0010.042
Reinhold (%EWL > 50%) (%)47.656.382.60.7911 (0.211; 2.972)0.3421 (0.125; 0.934)0.2711 (0.090; 0.812)
Long-term complications (%)61.962.515.70.8331 (0.214; 3.244)10.1051 (3.600; 28.367)8.4211 (2.733; 25.950)
2nd revisional procedure (n, %)10 (47.6%)5 (31.3%)1 (0.9%)NANANA
Improvement/ resolution in patients with 1 or more comorbidities (%)80 (8/10)60 (3/5)92.7 (38/41)0.3751 (0.081; 1.738)1.2471 (0.476; 3.265)0.4681 (0.126; 1.740)